| Filed On | Filing |
|---|---|
| 13 Jul 2023 |
8-K/A: Regulation FD Disclosure
2 | Corporate Presentation Q2 2023 Forward-Looking Statements This presentation has been prepared for informational purposes only from information supplied by Orchestra BioMed Holdings, Inc., referred to herein as “we,” “our,” “Orchestra... |
| 24 Mar 2023 |
8-K/A: Results of Operations and Financial Condition
To the Stockholders and the Board of Directors of Orchestra BioMed, Inc. |
Loading...
